Regulation Of Cigarettes And Smokeless Tobacco Under The Federal Food Drug And Cosmetic Act

The 111th Congress is considering legislation that would give the FDA broad new statutory authority to regulate the manufacture and marketing of cigarettes and smokeless tobacco products. This report provides a detailed summary of the proposed legislation and discusses the public health and legal issues it raises. Contents: (1) Views on FDA Tobacco Regulation: Public Health Viewpoint; Industry Viewpoint; (2) Proposed Tobacco Product Regulation: Reduced-Risk Tobacco Products; Tobacco Product Design and Characteristics; Menthol Cigarettes; (3) Legal Issues: Restrictions on Ads and Promotion; First Amend. Issues; Preemption of State and Local Regulation Re: Labeling, Ads, and Promotion; (4) Tobacco Master Settlement Agreement.

Includes: background on nicotine pharmacology; corporate relationship between British-American Tobacco Co. and Brown and Williamson Tobacco Co.; FDA letters to tobacco manufacturers; bibliography of industry-funded research; marketing of cigarettes and smokeless tobacco in the U.S.; citizen petitions and submitted comments; statements by David A. Kessler, M.D., Commissioner of Food and Drugs, on nicotine-containing cigarettes and on the control and manipulation of nicotine in cigarettes; and remarks by David A. Kessler, M.D., The Samuel Rubin Program, The Columbia University School of Law, March 8, 1995.